Publications
68
Citations
362
Est. group size
~31
Recurring co-author estimate
Active years
8
Publishing since 2019
Alma Habib works in blood cancer treatment, focusing on bone marrow and stem cell transplantation for conditions like multiple myeloma and lymphoma. Their research examines transplant outcomes, complications such as graft-versus-host disease and kidney injury, and factors affecting patient survival and access to advanced therapies like CAR-T cell treatment. Prospective students would engage with clinical and outcomes-based research using real-world patient data from transplant centers.
Publication output was minimal before 2022 but has grown sharply since 2023, reaching a peak of around 20 publications in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Long-Term Gynecologic and Reproductive Health in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis of Prevalence
Transplantation and Cellular Therapy · 2026
- Outcomes after Bone Marrow Versus Peripheral Blood Mismatched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GVHD Prophylaxis
Transplantation and Cellular Therapy · 2026
- High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis
Current Oncology · 2026
- Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
Transplantation and Cellular Therapy · 2026
- Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis
Blood · 2025
- Nephrons and non-relapse mortality: simplified comorbidity index and acute kidney injury are associated with NRM in adults undergoing allogeneic hematopoietic cell transplant
Frontiers in Transplantation · 2024
- Barriers to Commercial CAR-T Referral and Utilization for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Single-Institution Analysis
Transplantation and Cellular Therapy · 2023
- Nephrons and Non-Relapse Mortality (NRM): Simplified Comorbidity Index (SCI) and Acute Kidney Injury (AKI) Are Associated with NRM in Adults Undergoing Allogeneic Hematopoietic Cell Transplant
Transplantation and Cellular Therapy · 2023
- Heparin-Induced Thrombocytopenia in COVID-19
The Hematologist · 2022
- Global Health Education during the COVID-19 Pandemic: Challenges, Adaptations, and Lessons Learned
American Journal of Tropical Medicine and Hygiene · 2021
- Administration of and Prescribing Opioids in Emergency Departments: A Retrospective Study
Kansas Journal of Medicine · 2021
- Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma
Journal of Community Hospital Internal Medicine Perspectives · 2019
- Blood×19
- Transplantation and Cellular Therapy×9
- Current Oncology×4
- American Journal of Hematology×2
- Journal of Molecular and Cellular Cardiology×2
- Lynn O’Donnell
Medicine · The Ohio State University
- Audrey M. Sigmund
Medicine · The Ohio State University
- Nathan Denlinger
Medicine · The Ohio State University
- Evandro D. Bezerra
Medicine · The Ohio State University
- Utkarsh Acharya
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile